Preprint · CC-BY
via OpenAlex
The Optimal Treatments for Type 2 Diabetes from The Perspective of Anti-Aging Medicine
Hidekatsu Yanai, Hiroki Adachi, Mariko Hakoshima, Hisayuki Katsuyama
Preprints.org · 2025
Deregulated nutrient-sensing
Mitochondrial dysfunction
Chronic inflammation
Rapamycin / mTOR inhibition
Metformin
Human
Abstract
Aging is a complex biological process that involves a gradual decline in the human body's structure and function and increases the risks of aging-related diseases such as Alzheimer's disease (AD) and type 2 diabetes. Type 2 diabetes accelerates all clinical manifestations of aging. Metabolic disorders in type 2 diabetes are unfavorably associ-ated with all telomere(definition) attrition, cellular senescence(definition))." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">hallmarks of aging(definition) such as inflammation and mitochondrial dysfunction(definition). AMP-activated protein kinase (AMPK) and the mammalian target of mTOR(definition)-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">rapamycin(definition) com-plex 1 (mTORC1) are key players in cellular metabolism. AMPK activation and mTORC1 inhibition improve all hallmarks of aging. Furthermore, AMPK activation and mTORC1 inhibition are favorably associated with diabetic complications such as diabetic neuropathy, retinopathy, nephropathy and cardiovascular diseases and AD. Nutrition such as resveratrol and astaxanthin have AMPK activating and mTORC1 in-hibitory effects and improve metabolic abnormalities in type 2 diabetes. Metformin, sodium-glucose co-transporter-2 inhibitors, glucagon-like peptide 1 receptor agonists (GLP-1RAs), and dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 RAs, have been reported to have AMPK activating and mTORC1 inhibitory effects. The therapeutic interventions that activate AMPK and inhibit mTORC1 may be optimal treatments for type 2 diabetes from the perspective of anti-aging medicine.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.20944/preprints202508.0997.v1
- Canonical
- link ↗
- Fetched
- 2026-11-05 MST
Cite this
APA
Yanai, H., Adachi, H., Hakoshima, M., & Katsuyama, H. (2025). The Optimal Treatments for Type 2 Diabetes from The Perspective of Anti-Aging Medicine. <em>Preprints.org</em>. https://doi.org/10.20944/preprints202508.0997.v1
Vancouver
Yanai H, Adachi H, Hakoshima M, Katsuyama H. The Optimal Treatments for Type 2 Diabetes from The Perspective of Anti-Aging Medicine. Preprints.org. 2025. doi:10.20944/preprints202508.0997.v1.
BibTeX
@unpublished{hidekatsu2025TheOpt,
title = {The Optimal Treatments for Type 2 Diabetes from The Perspective of Anti-Aging Medicine},
author = {Hidekatsu Yanai and Hiroki Adachi and Mariko Hakoshima and Hisayuki Katsuyama},
journal = {Preprints.org},
year = {2025},
doi = {10.20944/preprints202508.0997.v1},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of Clinical Medicine Research 2025
Open access · CC-BY
Adenosine Monophosphate-Activated Protein Kinase Activation and Mammalian Target of Rapamycin Complex 1 Inhibition: A Mechanistic Rationale for Anti-Aging Therapy in Type 2 Diabetes
Journal of clinical medicine research 2025
Open access · OA
Adenosine Monophosphate-Activated Protein Kinase Activation and Mammalian Target of Rapamycin Complex 1 Inhibition: A Mechanistic Rationale for Anti-Aging Therapy in Type 2 Diabetes.
BioScience Trends 2023
Open access · OA
A circadian rhythm-restricted diet regulates autophagy to improve cognitive function and prolong lifespan
Biomedicines 2023
Open access · CC-BY
Dopamine in the Regulation of Glucose Homeostasis, Pathogenesis of Type 2 Diabetes, and Chronic Conditions of Impaired Dopamine Activity/Metabolism: Implication for Pathophysiological and Therapeutic Purposes
Elsevier eBooks 2018
Preprint · CC-BY
Pharmacological and Nonpharmacological Interventions for Cognitive Impairment and Dementia Related to Type 2 Diabetes and Metabolic Disturbances in Aging
Signal Transduction and Targeted Therapy 2026
Open access · CC-BY